Clinical trial Recruiting at 1 site Observational Ages 18 and up

Analgesia Nociception Index monitoring of the autonomic nervous system during continuous renal replacement therapy

Official title: Analgesia Nociception Index and Autonomic Nervous System Exploration During Continuous Renal Replacement Therapy in Intensive Care Patients.

Run by Hospices Civils de Lyon · NCT06285162 · Data updated 2026-11-12

We will try using the Analgesia Nociception Index to see if changes in autonomic signals match blood pressure and heart responses when fluid is removed during continuous renal replacement therapy in critically ill adults.

More Critically Ill trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Bron)
StatusRecruiting
StartedJanuary 9, 2026
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedJanuary 15, 2026
Trial IDNCT06285162 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult ICU patients receiving continuous renal replacement therapy who are undergoing net ultrafiltration, have invasive arterial and central venous lines, are in regular sinus rhythm, are not receiving inotropes or certain chronotropic agents, and meet the department's fluid-overload criteria would be ideal candidates.

Probably not a fit

Patients with arrhythmias, on inotropes, beta-blockers, or alpha-2 agonists, those with known dysautonomia, pregnant or breastfeeding patients, or those lacking invasive monitoring are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational protocol that continuously records the Analgesia Nociception Index (ANI) alongside invasive hemodynamic measurements in ICU patients on continuous renal replacement therapy (CRRT) undergoing net ultrafiltration. Eligible patients have invasive arterial and central venous monitoring, regular sinus rhythm, and meet local fluid-overload and stability criteria, while patients on inotropes, beta-blockers, or with dysautonomia are excluded. ANI and standard vital signs will be captured before, during, and after fluid removal and analyzed for temporal associations with blood pressure and heart rate changes. No changes to clinical care are mandated by the protocol; data are collected from routine CRRT sessions to characterize autonomic-related hemodynamic variation.

Why it matters

Potential benefit: If successful, this could help clinicians detect autonomic-driven hemodynamic instability during fluid removal and guide safer ultrafiltration choices.

How similar studies have gone: ANI has been used to monitor autonomic tone and nociception in anesthesia and some ICU settings, but applying it specifically to hemodynamic effects during ultrafiltration in CRRT is novel and only sparsely studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Continuous renal replacement therapy in intensive care unit
* Initiation of net ultrafiltration according to the protocol of the department or to EARLYDRY study (NCT 05817539) (3 criteria required):

  * Fluid overload \> 5% or peripheral oedema
  * Noradrenaline equivalent \<0.5μg/kg/min
  * No peripheral hypoperfusion
* Invasive blood pressure monitoring
* Central venous line in superior vena cava territory
* Regular sinus rhythm
* Patient awake or Richmond Agitation and Sedation Scale \> -3

Exclusion Criteria:

* Ongoing administration of inotropes
* Ongoing administration of beta blockers
* Current administration of alpha-2 agonists
* History of dysautonomia
* Pregnant or breast-feeding woman
* Mechanical circulatory assistance
* Opposition to participate
* Adults under legal protection
* Persons deprived of their liberty by judicial or administrative decision

Where it's running

  • Département d'anesthésie-réanimation Hôpital cardiologique Louis Pradel
    Bron, France
    Recruiting

Study contacts

  • Principal investigator: Martin RUSTE, MD — Département d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, HCL
  • Study coordinator: Martin RUSTE, MD
  • Email: martin.ruste@chu-lyon.fr
  • Phone: +33472118956

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.